Botanical species · safety record

Coleus forskohlii

The EFSA Compendium of Botanicals holds 10 constituent measurements and 1 adverse-effect record for Coleus forskohlii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Coleus forskohlii (Willd.) Briq.

10Constituent measurements
1Safety records
6Cited sources
32Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 32 licensed products naming Coleus forskohlii as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Leaf
  • Root
  • Root (standardized extract)
  • Root extract
  • Root extract (standardised)
  • leaf standardized extract

What the records describe

Constituents measured

  • Forskolin5
  • Alkaloids1
  • Cardiac glycosides1
  • Coumarins1
  • Labdane diterpenes1
  • Saponins1

Plant parts

  • Roots and other underground parts8
  • Aerial part of plants1
  • Leaves1
  • Stem1
  • stalk1

Preparations

  • Solvent extraction8
  • Super-critical gas extraction3

Effect types

  • Hepatotoxicity1

Target tissues

  • Liver1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionPhytochemical screeningResolve DOI
CoumarinsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
ForskolinRoots and other underground partsSuper-critical gas extraction≥ 20 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
ForskolinRoots and other underground partsSuper-critical gas extraction≤ 30 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Labdane diterpenesRoots and other underground partsSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
SaponinsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
Cardiac glycosidesRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
ForskolinAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
ForskolinRoots and other underground partsSolvent extraction0.3 PercentLC-MSNo resolvable identifier
ForskolinStem / stalkSolvent extraction0.03 PercentLC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverRoots and other underground partsSuper-critical gas extractionHouse mouse (as animal)Short-term toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Virgona, Nantiga., Taki, Yuko., Yamada, Shizuo., Umegaki, Keizo. Dietary Coleus forskohlii extract generates dose-related hepatotoxicity in mice . Journal of applied toxicology, 2013, vol. 33, no. 9, p. 924-932. DOI
  2. Bodiwala, Hardik S., Sabde, Sudeep., Mitra, Debashis., Bhutani, Kamlesh Kumar., Singh, Inder Pal. Anti-MV Diterpenes from Coleus forskohlii. Natural product communications, 2009, vol. 4, no. 9, p. 1173-1175.
  3. Schaneberg, BT., Khan, IA. Quantitative analysis of forskolin in Coleus forskohlii (Lamiaceae) by reversed-phase liquid chromatography . Journal of aoac international, 2003, vol. 86, no. 3, p. 467-470.
  4. Takshak, Swabha., Agrawal, S. B. The role of supplemental ultraviolet-B radiation in altering the metabolite profile, essential oil content and composition, and free radical scavenging activities of Coleus forskohlii, an indigenous medicinal plant . Environmental science and pollution research, 2016, vol. 23, no. 8, p. 7324-7337. DOI
  5. Khatun, Selima., Cakilcioglu, Ugur., Chatterjee, Narayan Chandra. Phytochemical constituents vis-a-vis histochemical localization of forskolin in a medicinal plant Coleus forskohlii Briq. . Journal of medicinal plants research, 2011, vol. 5, no. 5, p. 711-718.
  6. ROY, R., MISHRA, A., VARMA, N., TANDON, JS., SAUX, M., CARPY, A. MINOR DITERPENES FROM COLEUS-FORSKOHLII. Phytochemistry, 1993, vol. 34, no. 6, p. 1577-1580. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue